| AqueSys Fills Up With $35 Million Venture Capital |
|
|
| Wednesday, June 30, 2010 5:33:00 AM PDT | VentureDeal Staff |
Irvine, California -- Medical device company AqueSys has secured $35 million in its third round of institutional venture capital investment.
AqueSys is in clinical trials for the development of a device to treat primary open angle glaucoma.
Longitude Capital Management and Rho Ventures led the round, which also included Accuitive Medical Ventures, the Carlyle Group and SV Life Sciences. |
|
|
 Email Page |  Print Page |
|
|
|
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
|
 |
|
|
|
 |